TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade In Vitro and In Vivo
Year: 2019
Type: article
Source: Molecular Cancer Therapeutics
Authors: Srimoyee Ghosh, Geeta Sharma, Jon Travers, Sujatha Kumar, Justin Choi, H. Toni Jun, Marilyn Kehry, Sridhar Ramaswamy, David Jenkins
Institutions: Tesaro (United States), AnaptysBio, Inc. (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: LAG-3, anti-PD-1 therapy, immune checkpoint inhibitors, T cell activation, non-small cell lung cancer, tumor-infiltrating lymphocytes, immunosuppressive tumor microenvironment, combination immunotherapy, humanized monoclonal antibody, interferon-gamma, immunological memory, cancer immunotherapy
Open Access status: closed
OpenAlex ID: W2906596920
